Cost of illness of metastatic prostate cancer: a perspective of costs for new treatment options in The Netherlands

To assess the resource use and associated costs of treating patients with metastatic prostate cancer with a focus on skeletal-related events (SREs).

We performed a bottom-up cost of illness study in The Netherlands.

A total of 136 patients were studied. The mean total costs were €17,931 per patient. SREs that required hospitalization (n = 53) were, at median costs of €2039-9346, depending on care. These SREs had median costs of €200-1912.

Our data provide a basis to investigate the cost-effectiveness of novel treatment options for metastatic prostate cancer. The impact of SREs on total costs could justify policy aimed at actively preventing SREs, possibly resulting in better quality of life and cost-reduction.

Journal of comparative effectiveness research. 2017 Sep 13 [Epub]

Rob Ter Heine, Geert Wj Frederix, Joost W Geenen, Anke M Hövels, Marco van Vulpen, Anko Kooistra, John Mh De Klerk, Haiko J Bloemendal

Radboudumc, Department of Pharmacy, Geert Grooteplein-Zuid 22, 6525 GA, Nijmegen, The Netherlands., Julius Center for Health Sciences & Primary Care, University Medical Center, Universiteitsweg 100, 3584 CG Utrecht, The Netherlands., University Utrecht, Faculty of Science, Department of Pharmaceutical Sciences, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands., University Medical Centre Utrecht, Department of Radiotherapy, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands., Meander Medical Centre, Department of Urology, Maatweg 3, 3813 TZ, Amersfoort, The Netherlands., Meander Medical Centre, Department of Nuclear Medicine, Maatweg 3, 3813 TZ, Amersfoort, The Netherlands., Meander Medical Centre, Department of Internal Medicine, Maatweg 3, 3813 TZ, Amersfoort, The Netherlands.

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe